Phibro Animal Health (PAHC) Accounts Payables (2013 - 2026)

Phibro Animal Health has reported Accounts Payables for 14 years, with the latest figure at $127.3 million in Q2 2026.

• On a quarterly basis, Accounts Payables fell 7.88% year-over-year to $127.3 million in Q2 2026; TTM through Jun 2026 was $127.3 million, a 7.88% decrease from a year earlier, with the FY2026 full-year figure at $127.3 million, down 7.88% from the prior year.
• Accounts Payables was $127.3 million for Q2 2026 at Phibro Animal Health, down from $129.6 million in the prior quarter.
• The five-year high for Accounts Payables was $138.2 million in Q2 2025, with the low at $73.9 million in Q2 2023.
• Average Accounts Payables over 5 years is $100.7 million, with a median of $89.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables fell 22.74% in 2023, then jumped 61.51% in 2025.
• Over 5 years, Accounts Payables stood at $80.5 million in 2022, then advanced by 7.36% to $86.4 million in 2023, then rose by 15.09% to $99.4 million in 2024, then surged by 34.04% to $133.3 million in 2025, then dropped by 4.49% to $127.3 million in 2026.
• The last three Accounts Payables figures came in at $127.3 million (Q2 2026), $129.6 million (Q1 2026), and $133.3 million (Q4 2025), per Business Quant data.